March 2014 Issue Table Of Contents
Source: Life Science Leader
![LSLEAD_COV1_March LSLEAD_COV1_March](https://vertassets.blob.core.windows.net/image/4cd7bb7b/4cd7bb7b-48f0-4cd9-9b51-3e3674fbb767/375_250-lslead_cov1_march.jpg)
From The Editor
Capitol Perspectives
Companies To Watch
Outsourcing Insights
Bio Innovation notes
Features
- Paul Stoffels Expands The Janssen Legacy
- Medicago’s Innovative Vaccine Production Using Tobacco Plants
- Dennis Purcell Building On Last Year’s Biotech Boom In 2014
- Maintaining Momentum: 2014 Pharma & Funding Forecasts At JPMHCC
Inside The Industry
- How Rare Disease Know-how Can Shape Big Pharma Clinical Trials
- Transform Clinical Trials By Embracing M2M Technology
- Nonantibiotics Spur Biotech-Pharma Collaborations
- Patient-Centric Design: The Next Frontier In Drug Delivery
- Serilalization – Pharma Faces 2015 Deadline
- Evolva Turns Around Its Business Model: Swiss Biotech Opts Out Of Drug Development
Industry Leader
Leadership Lessons
Ask The Board
This website uses cookies to ensure you get the best experience on our website. Learn more